Overview
Availability
- Professor Steve Deitelzweig is:
- Available for supervision
Works
Search Professor Steve Deitelzweig’s works on UQ eSpace
2016
Journal Article
Pulmonary embolism inpatients treated with rivaroxaban had shorter hospital stays and lower costs compared with warfarin
Margolis, Jay M., Deitelzweig, Steven, Kline, Jeffrey, Tran, Oth, Smith, David M., Crivera, Concetta, Bookhart, Brahim and Schein, Jeff (2016). Pulmonary embolism inpatients treated with rivaroxaban had shorter hospital stays and lower costs compared with warfarin. Clinical Therapeutics, 38 (11), 2496-2503. doi: 10.1016/j.clinthera.2016.09.007
2016
Journal Article
Shorter hospital stays and lower costs for rivaroxaban compared with warfarin for venous thrombosis admissions
Margolis, Jay M., Deitelzweig, Steven, Kline, Jeffrey, Tran, Oth, Smith, David M., Bookhart, Brahim, Crivera, Concetta and Schein, Jeff (2016). Shorter hospital stays and lower costs for rivaroxaban compared with warfarin for venous thrombosis admissions. Journal of the American Heart Association, 5 (10) e003788. doi: 10.1161/JAHA.116.003788
2016
Journal Article
Hospitalizations and other health care resource utilization among patients with deep vein thrombosis treated with rivaroxaban versus low-molecular-weight heparin and warfarin in the outpatient setting
Deitelzweig, Steven, Laliberte, Francois, Crivera, Concetta, Germain, Guillaume, Bookhart, Brahim K., Olson, William H., Schein, Jeffrey and Lefebvre, Patrick (2016). Hospitalizations and other health care resource utilization among patients with deep vein thrombosis treated with rivaroxaban versus low-molecular-weight heparin and warfarin in the outpatient setting. Clinical Therapeutics, 38 (8), 1803-1816. doi: 10.1016/j.clinthera.2016.07.002
2016
Journal Article
Multidrug-resistant gram-negative bacterial infections in the hospital setting: Overview, implications for clinical practice, and emerging treatment options
Cerceo, Elizabeth, Deitelzweig, Steven B., Sherman, Bradley M. and Amin, Alpesh N. (2016). Multidrug-resistant gram-negative bacterial infections in the hospital setting: Overview, implications for clinical practice, and emerging treatment options. Microbial Drug Resistance, 22 (5), 412-431. doi: 10.1089/mdr.2015.0220
2016
Journal Article
Warfarin time in therapeutic range and its impact on healthcare resource utilization and costs among patients with nonvalvular atrial fibrillation
Deitelzweig, Steve, Evans, Michael, Hillson, Eric, Trocio, Jeffrey, Bruno, Amanda, Tan, Wilson, Lingohr-Smith, Melissa, Singh, Prianka and Lin, Jay (2016). Warfarin time in therapeutic range and its impact on healthcare resource utilization and costs among patients with nonvalvular atrial fibrillation. Current Medical Research and Opinion, 32 (1), 87-94. doi: 10.1185/03007995.2015.1103217
2016
Conference Publication
Compare major bleeding risk and associated costs among Nvaf patients with Cha2Ds2-vasc score >= 3 newly anticoagulated with apixaban versus warfarin
Deitelzweig, Steven, Gupta, Kiran, Ogbonnaya, Augustina, Shah, Manan, Farrelly, Eileen, Lokhandwala, Tasneem, Eaddy, Michael and Squibb, Bristol-Myers (2016). Compare major bleeding risk and associated costs among Nvaf patients with Cha2Ds2-vasc score >= 3 newly anticoagulated with apixaban versus warfarin. 65th Annual Scientific Session and Expo of the American College of Cardiology (ACC), Chicago, United States, April 02-04, 2016. San Diego, United States: Elsevier. doi: 10.1016/S0735-1097(16)30877-4
2016
Conference Publication
Hospital readmissions among patients with nonvalvular atrial fibrillation treated with the new oral anticoagulants, apixaban, dabigatran, and rivaroxaban
Deitelzweig, Steven, Gupta, Kiran, Nadkarni, Anagha, Trocio, Jeffrey, Lin, Jay and Lingohr-Smith, Melissa (2016). Hospital readmissions among patients with nonvalvular atrial fibrillation treated with the new oral anticoagulants, apixaban, dabigatran, and rivaroxaban. 65th Annual Scientific Session and Expo of the American College of Cardiology (ACC), Chicago, United States, April 02-04, 2016. San Diego, United States: Elsevier. doi: 10.1016/S0735-1097(16)30806-3
2016
Conference Publication
Hospital resource utilization, cost and inpatient mortality associated with hospitalizations for major bleeding among atrial fibrillation patients treated with factor Xa inhibitors
Deitelzweig, S., Neuman, R., Lingohr-Smith, M. and Lin, J. (2016). Hospital resource utilization, cost and inpatient mortality associated with hospitalizations for major bleeding among atrial fibrillation patients treated with factor Xa inhibitors. Congress of the European-Society-of-Cardiology (ESC), Rome Italy, Aug 27-31, 2016. OXFORD: OXFORD UNIV PRESS.
2016
Conference Publication
Hospital Length Of Stay And Hospitalization Costs For Pulmonary Embolism Comparing Patients Receiving Rivaroxaban Or Warfarin
Kline, J. A., Deitelzweig, S., Margolis, J. M., Raut, M., Tran, O., Smith, D. M., Crivera, C., Bookhart, B., Schein, J. and Olson, W. (2016). Hospital Length Of Stay And Hospitalization Costs For Pulmonary Embolism Comparing Patients Receiving Rivaroxaban Or Warfarin. International Conference of the American-Thoracic-Society (ATS), San Francisco, United States, May 13-18, 2016. NEW YORK: AMER THORACIC SOC.
2016
Conference Publication
An early evaluation of bleeding-related hospital readmissions among hospitalized patients with nonvalvular atrial fibrillation treated with direct oral anticoagulants
Deitelzweig, Steve, Bruno, Amanda, Trocio, Jeffrey, Tate, Natalie, Gupta, Kiran, Lin, Jay and Lingohr-Smith, Melissa (2016). An early evaluation of bleeding-related hospital readmissions among hospitalized patients with nonvalvular atrial fibrillation treated with direct oral anticoagulants. Abingdon, Oxfordshire, United Kingdom: Taylor & Francis. doi: 10.1185/03007995.2015.1131676
2016
Conference Publication
Comparison of rivaroxaban or warfarin use for venous thromboembolism on inpatient length of stay
Deitelzweig, Steven, Kline, Jeffrey, Margolis, Jay M., Raut, Monika, Tran, Oth, Smith, David, Crivera, Concetta, Bookhart, Brahim, Schein, Jeff and Olson, William (2016). Comparison of rivaroxaban or warfarin use for venous thromboembolism on inpatient length of stay. 65th Annual Scientific Session and Expo of the American College of Cardiology (ACC), Chicago, United States, April 02-04, 2016. San Diego, United States: Elsevier. doi: 10.1016/S0735-1097(16)32066-6
2016
Conference Publication
Health Care Costs Among Patients Diagnosed with Deep Vein Thrombosis in the Outpatient Setting and Treated with Rivaroxaban Versus Low-Molecular-Weight Heparin and Warfarin
Deitelzweig, S., Laliberte, F., Raut, R., Germain, G., Bookhart, B. K., Olson, W. H., Schein, J. and Lefebvre, P. (2016). Health Care Costs Among Patients Diagnosed with Deep Vein Thrombosis in the Outpatient Setting and Treated with Rivaroxaban Versus Low-Molecular-Weight Heparin and Warfarin. ISPOR 21st Annual International Meeting, Washington, DC United States, 21 – 25 May 2016. New York, NY United States: Elsevier. doi: 10.1016/j.jval.2016.03.102
2015
Journal Article
Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure
McHorney, Colleen A., Crivera, Concetta, Laliberte, Francois, Nelson, Winnie W., Germain, Guillaume, Bookhart, Brahim, Martin, Silas, Schein, Jeffrey, Lefebvre, Patrick and Deitelzweig, Steven (2015). Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure. Current Medical Research and Opinion, 31 (12), 2167-2173. doi: 10.1185/03007995.2015.1096242
2015
Journal Article
A case-based approach to implementing guidelines for stroke prevention in patients with atrial fibrillation: Balancing the risks and benefits
Amin, Alpesh and Deitelzweig, Steven (2015). A case-based approach to implementing guidelines for stroke prevention in patients with atrial fibrillation: Balancing the risks and benefits. Thrombosis Journal, 13 (29) 29, 29. doi: 10.1186/s12959-015-0056-y
2015
Journal Article
Comparison of medical costs of patients with atrial fibrillation unsuitable for warfarin treatment with apixaban or aspirin based on averroes trial
Amin, Alpesh, Deitelzweig, Steve, Jing, Yonghua, Makenbaeva, Dinara, Wiederkehr, Daniel, Lin, Jay and Graham, John (2015). Comparison of medical costs of patients with atrial fibrillation unsuitable for warfarin treatment with apixaban or aspirin based on averroes trial. Clinical and Applied Thrombosis/Hemostasis, 21 (3), 235-240. doi: 10.1177/1076029613507335
2015
Conference Publication
Comparison of Major Bleeding Risk and Associated Costs Among Newly Anticoagulated Non-valvular Atrial Fibrillation Patients
Deitelzweig, Steven, Bruno, Amanda, Tate, Natalie, Ogbonnaya, Augustina, Shah, Manan, Farrelly, Eileen, Lokhandwala, Tasneem, Gupta, Kiran and Eaddy, Michael (2015). Comparison of Major Bleeding Risk and Associated Costs Among Newly Anticoagulated Non-valvular Atrial Fibrillation Patients. Scientific Sessions and Resuscitation Science Symposium of the American-Heart-Association (AHA), Orlando, United States, Nov 07-11, 2015. LIPPINCOTT WILLIAMS & WILKINS.
2015
Conference Publication
Major bleeding, hospitalisation rates and healthcare costs among non-valvular atrial fibrillation patients naive to oral anticoagulation and newly treated with novel oral anticoagulants
Deitelzweig, S., Bruno, A., Tate, N., Ogbonnaya, A., Shah, M., Farrelly, E., Lokhandwala, T., Gupta, K. and Eaddy, M. (2015). Major bleeding, hospitalisation rates and healthcare costs among non-valvular atrial fibrillation patients naive to oral anticoagulation and newly treated with novel oral anticoagulants. Congress of the European-Society-of-Cardiology (ESC), London, England, United Kingdom, Aug 29-Sep 02, 2015. OXFORD: OXFORD UNIV PRESS.
2015
Conference Publication
Early assessment of bleeding-related hospital readmissions among nonvalvular atrial fibrillation patients treated with the new oral anticoagulants using an electronic medical record database in the US
Deitelzweig, S., Bruno, A., Trocio, J., Tate, N., Gupta, K., Lin, J. and Lingohr-Smith, M. (2015). Early assessment of bleeding-related hospital readmissions among nonvalvular atrial fibrillation patients treated with the new oral anticoagulants using an electronic medical record database in the US. Congress of the European-Society-of-Cardiology (ESC), London, England, United Kingdom, Aug 29-Sep 02, 2015. OXFORD: OXFORD UNIV PRESS.
2015
Conference Publication
A Conservative Aproach to Assess Warfarin Time-in-Therapeutic Ranges Among Nonvalvular Atrial Fibrillation Patients in An Integrated Healthcare Delivery System Setting in the U.S
Deitelzweig, S., Evans, M., Hillson, E., Trocio, J., Bruno, A., Tan, W., Lingohr-Smith, M. and Lin, J. (2015). A Conservative Aproach to Assess Warfarin Time-in-Therapeutic Ranges Among Nonvalvular Atrial Fibrillation Patients in An Integrated Healthcare Delivery System Setting in the U.S. ISPOR 20th Annual International Meeting, Philadelphia, PA United States, 16-20 May 2015. New York, NY United States: Elsevier. doi: 10.1016/j.jval.2015.03.848
2014
Conference Publication
Evaluation of Differences in Medical Costs Associated with Venous Thromboembolism Prophylaxis with Desirudin Vs. Low Molecular Weight Heparin Among Patients Undergoing Total Hip Replacement Surgery
Deitelzweig, Steven, Nutescu, Edith A., Meyer, James, Lin, Jay, Lingohr-Smith, Melissa and Amin, Alpesh N. (2014). Evaluation of Differences in Medical Costs Associated with Venous Thromboembolism Prophylaxis with Desirudin Vs. Low Molecular Weight Heparin Among Patients Undergoing Total Hip Replacement Surgery. 56th Annual Meeting of the American-Society-of-Hematology, San Francisco Ca, Dec 06-09, 2014. WASHINGTON: AMER SOC HEMATOLOGY.
Supervision
Availability
- Professor Steve Deitelzweig is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Media
Enquiries
For media enquiries about Professor Steve Deitelzweig's areas of expertise, story ideas and help finding experts, contact our Media team: